Karen Parker

1.6k total citations · 1 hit paper
23 papers, 1.2k citations indexed

About

Karen Parker is a scholar working on Education, Molecular Biology and Oncology. According to data from OpenAlex, Karen Parker has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Education, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Karen Parker's work include Renal Transplantation Outcomes and Treatments (5 papers), Virus-based gene therapy research (3 papers) and CAR-T cell therapy research (2 papers). Karen Parker is often cited by papers focused on Renal Transplantation Outcomes and Treatments (5 papers), Virus-based gene therapy research (3 papers) and CAR-T cell therapy research (2 papers). Karen Parker collaborates with scholars based in United States, Australia and Netherlands. Karen Parker's co-authors include William T. Kendrick, Paul Bolin, Lorita M. Rebellato, Scott A. Kendrick, Miyuki Ozawa, Robert C. Harland, Carl E. Haisch, Kimberly P. Briley, Matthew J. Everly and Paul I. Terasaki and has published in prestigious journals such as Cancer, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Karen Parker

22 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence and Impact of De Novo Donor-Specific Alloantibody in Primary Renal Allografts

2013 292 citations Matthew J. Everly, Lorita M. Rebellato et al. Transplantation profile →

Peers

Countries citing papers authored by Karen Parker

Since Specialization

Citations

This map shows the geographic impact of Karen Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Parker more than expected).

Fields of papers citing papers by Karen Parker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Parker. The network helps show where Karen Parker may publish in the future.

Co-authorship network of co-authors of Karen Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Parker. A scholar is included among the top collaborators of Karen Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Parker. Karen Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Post-acute sequelae of SARS-CoV-2 infection (Long COVID) in older adults 2024 ·GeroScience ·Samantha Russell, Karen Parker, Andrea Lehoczki, David Lieberman, (unknown), (unknown), Linda R. Phillips, Mindy J. Fain, Janko Nikolich‐Žugich	14
2	Cancer disparities among sexual and gender minority populations 2023 ·Journal of the National Medical Association ·Sarah S. Jackson, Shyam A. Patel, Karen Parker	11
3	Early Lessons from Evaluation of Computer Science Teacher Professional Development in Google’s CS4HS Program 2017 ·ACM Transactions on Computing Education ·Jason Ravitz, Chris Stephenson, Karen Parker, (unknown)	27
4	Childhood Cancers: Diagnostic Considerations 2017 ·The Journal for Nurse Practitioners ·Karen Parker, (unknown)	1
5	Enteric-Coated Mycophenolate Sodium and Gastrointestinal Prophylaxis in Renal Transplant Patients 2015 ·Karen Parker, (unknown), (unknown), (unknown), Paul Bolin	1
6	Sexual and Gender Minority Health Research at the National Institutes of Health 2015 ·LGBT Health ·(unknown), Karen Parker, Tara A. Schwetz	37
7	Improved Long-Term Survival in Kidney Transplant Recipients with Donor-Specific HLA Antibodies After Mycophenolic Acid Escalation. 2014 ·PubMed ·Lorita M. Rebellato, Karen Parker, Matthew J. Everly, Kimberly P. Briley, William T. Kendrick, Scott A. Kendrick, Carl E. Haisch, Paul I. Terasaki, Paul Bolin	2
8	Incidence and Impact of De Novo Donor-Specific Alloantibody in Primary Renal Allografts breakdown → 2013 ·Transplantation ·Matthew J. Everly, Lorita M. Rebellato, Carl E. Haisch, Miyuki Ozawa, Karen Parker, Kimberly P. Briley, Paul G. Catrou, Paul Bolin, William T. Kendrick, Scott A. Kendrick, Robert C. Harland, Paul I. Terasaki	292
9	Character Traits Depicted in Newbery Medal Books from the 1920s Through the 2000s 2013 ·Journal of Research on Christian Education ·(unknown), Karen Parker	1
10	The Role of Immunoglobulin-G Subclasses and C1q in De Novo HLA-DQ Donor-Specific Antibody Kidney Transplantation Outcomes 2013 ·Transplantation ·Maria Cecília S. Freitas, Lorita M. Rebellato, Miyuki Ozawa, Anh Nguyen, Nori Sasaki, Matthew J. Everly, Kimberly P. Briley, Carl E. Haisch, Paul Bolin, Karen Parker, William T. Kendrick, Scott A. Kendrick, Robert C. Harland, Paul I. Terasaki	146
11	A report of the epidemiology of de novo donor-specific anti-HLA antibodies (DSA) in "low-risk" renal transplant recipients. 2011 ·PubMed ·Lorita M. Rebellato, (unknown), Carl E. Haisch, Miyuki Ozawa, Kimberly P. Briley, Karen Parker, Paul G. Catrou, Paul Bolin, William T. Kendrick, Scott A. Kendrick, Robert C. Harland	9
12	Collective teacher efficacy, pupil attainment and socio-economic status in primary school® 2006 ·Improving Schools ·Karen Parker, Elizabeth Hannah, Keith J. Topping	36
13	The pluripotency homeobox gene NANOG is expressed in human germ cell tumors 2005 ·Cancer ·Adam H. Hart, Lynne Hartley, Karen Parker, (unknown), Leendert H. J. Looijenga, (unknown), C.W. Chow, Lorraine Robb	196
14	Transcriptional regulation of the homeobox gene Mixl1 by TGF-β and FoxH1 2005 ·Biochemical and Biophysical Research Communications ·Adam H. Hart, Tracy A. Willson, (unknown), Karen Parker, Lorraine Robb	21
15	Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study 2004 ·Molecular Therapy ·Casey Cunningham, Sunil Chada, James A. Merritt, Alex Tong, Neil Senzer, Yuan Zhang, Abner M. Mhashilkar, Karen Parker, S. Vukelja, Don S. Richards, Jill Hood, Keith Coffee, John Nemunaitis	166
16	Evidence That Transfer of Functional p53 Protein Results in Increased Apoptosis in Prostate Cancer 2004 ·Clinical Cancer Research ·Louis L. Pisters, Curtis A. Pettaway, Patricia Troncoso, Timothy J. McDonnell, L. Clifton Stephens, Christopher G. Wood, Kim‐Anh Do, Shawn Brisbay, Xuemei Wang, Elizabeth Hossan, Robert B. Evans, (unknown), (unknown), Karen Parker, James A. Merritt, Mitchell S. Steiner, Christopher J. Logothetis	38
17	Intratumoral Injection of INGN 241, a Nonreplicating Adenovector Expressing the Melanoma-Differentiation Associated Gene-7 (mda-7/IL24): Biologic Outcome in Advanced Cancer Patients 2004 ·Molecular Therapy ·Alex W. Tong, John Nemunaitis, Dan Su, Yuan Zhang, Casey Cunningham, Neil Senzer, George J. Netto, (unknown), (unknown), Karen Parker, Keith Coffee, Rajagopal Ramesh, Sühendan Ekmekçioglu, Elizabeth A. Grimm, Jill Hood, James A. Merritt, Sunil Chada	165
18	Inner strength in Salvadoran women: a secondary analysis. 2003 ·PubMed ·(unknown), Karen Parker	6
19	Increased Endothelial Permeability after Neutrophil Activation Occurs by a Diffusion-Dependent Mechanism 1995 ·Microvascular Research ·(unknown), Karen Parker, A. Siflinger-Birnboim, Asrar B. Malik	11
20	A Problem-Based Learning Course for Pharmacy Students on Alcohol and Psychoactive Substance Abuse Disorders 1994 ·American Journal of Pharmaceutical Education ·Usoa Busto, (unknown), E Janecek, (unknown), Karen Parker	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact